BR112012004967B8 - forma de dosagem oral, compreendendo pelo menos um agente biologicamente ativo, substâncias auxiliares da formulação e partículas magnetizáveis, seu uso e seu método de produção - Google Patents

forma de dosagem oral, compreendendo pelo menos um agente biologicamente ativo, substâncias auxiliares da formulação e partículas magnetizáveis, seu uso e seu método de produção

Info

Publication number
BR112012004967B8
BR112012004967B8 BR112012004967A BR112012004967A BR112012004967B8 BR 112012004967 B8 BR112012004967 B8 BR 112012004967B8 BR 112012004967 A BR112012004967 A BR 112012004967A BR 112012004967 A BR112012004967 A BR 112012004967A BR 112012004967 B8 BR112012004967 B8 BR 112012004967B8
Authority
BR
Brazil
Prior art keywords
dosage form
magnetizable particles
active agent
biologically active
oral dosage
Prior art date
Application number
BR112012004967A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112012004967B1 (pt
BR112012004967A2 (pt
Inventor
Hartwig Benedikt
Windhab Norbert
Liefke Melanie
Tome Alcalde Juan
Damm Michael
Lizio Rosario
Gottschalk Michael
Olf Angela
Meier Christian
Gryczke Andreas
Original Assignee
Evonik Roehm Gmbh
Roehm Gmbh
Evonik Degussa Gmbh
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh, Roehm Gmbh, Evonik Degussa Gmbh, Evonik Operations Gmbh filed Critical Evonik Roehm Gmbh
Publication of BR112012004967A2 publication Critical patent/BR112012004967A2/pt
Publication of BR112012004967B1 publication Critical patent/BR112012004967B1/pt
Publication of BR112012004967B8 publication Critical patent/BR112012004967B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112012004967A 2009-09-03 2010-08-30 forma de dosagem oral, compreendendo pelo menos um agente biologicamente ativo, substâncias auxiliares da formulação e partículas magnetizáveis, seu uso e seu método de produção BR112012004967B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23961309P 2009-09-03 2009-09-03
DE102009029170 2009-09-03
DE102009029170.9 2009-09-03
US61/239,613 2009-09-03
PCT/EP2010/062641 WO2011026808A1 (en) 2009-09-03 2010-08-30 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles

Publications (3)

Publication Number Publication Date
BR112012004967A2 BR112012004967A2 (pt) 2016-04-05
BR112012004967B1 BR112012004967B1 (pt) 2021-05-11
BR112012004967B8 true BR112012004967B8 (pt) 2022-07-05

Family

ID=42984007

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012004967A BR112012004967B8 (pt) 2009-09-03 2010-08-30 forma de dosagem oral, compreendendo pelo menos um agente biologicamente ativo, substâncias auxiliares da formulação e partículas magnetizáveis, seu uso e seu método de produção

Country Status (13)

Country Link
US (1) US9050256B2 (cg-RX-API-DMAC7.html)
EP (1) EP2473095B1 (cg-RX-API-DMAC7.html)
JP (1) JP5868319B2 (cg-RX-API-DMAC7.html)
KR (1) KR101731130B1 (cg-RX-API-DMAC7.html)
CN (1) CN102573612B (cg-RX-API-DMAC7.html)
BR (1) BR112012004967B8 (cg-RX-API-DMAC7.html)
CA (1) CA2772708C (cg-RX-API-DMAC7.html)
ES (1) ES2528494T3 (cg-RX-API-DMAC7.html)
IL (1) IL217897A (cg-RX-API-DMAC7.html)
MX (1) MX2012002677A (cg-RX-API-DMAC7.html)
PL (1) PL2473095T3 (cg-RX-API-DMAC7.html)
SI (1) SI2473095T1 (cg-RX-API-DMAC7.html)
WO (1) WO2011026808A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103796626A (zh) * 2011-09-14 2014-05-14 佛罗里达大学 Smarttm固体口服剂型
DE102011089334A1 (de) 2011-12-21 2013-06-27 Evonik Röhm Gmbh Detektionssystem zur Erfassung magnetischer Objekte im menschlichen Organismus
US11667906B2 (en) * 2014-11-24 2023-06-06 Corning Incorporated Magnetic microcarriers
US11024449B2 (en) * 2017-06-06 2021-06-01 Apple Inc. Multipole elastomeric magnet with magnetic-field shunt
WO2019110321A1 (de) 2017-12-04 2019-06-13 Evonik Röhm Gmbh Maskierung und nachfolgende sichtbarmachung von esr signalen mittels der kombination von zwei materialien
US10824822B2 (en) * 2019-02-05 2020-11-03 International Business Machines Corporation Magnetic tracking for medicine management
US10679018B1 (en) 2019-02-05 2020-06-09 International Business Machines Corporation Magnetic tracking for medicine management
JP7502741B2 (ja) * 2019-09-26 2024-06-19 スピンセンシングファクトリー株式会社 磁気マーカーおよび磁気マーカー検出システム
AU2021356684A1 (en) 2020-10-09 2023-05-11 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
CN112360304A (zh) * 2020-11-06 2021-02-12 炫丽建材江苏有限公司 一种适用于22度免拉手门板的自愈合封边工艺
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
US20250250326A1 (en) 2022-04-06 2025-08-07 The Trustees Of The University Of Pennsylvania Passive immunization with anti-aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors
CA3247109A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Compositions and treatment methods for metastatic breast cancer that is human epidermal growth factor receptor 2 positive and other cancers
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en) 2023-12-08 2026-06-18 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723310A1 (de) * 1987-07-15 1989-01-26 John Urquhart Pharmazeutisches praeparat und verfahren zu seiner herstellung
DE3740187A1 (de) 1987-11-27 1989-06-08 Urquhart John Verfahren und vorrichtung zum ueberwachen und/oder kontrollieren und/oder registrieren und/oder anzeigen der einnahme von pharmazeutischen praeparaten
DE3940260A1 (de) 1989-03-04 1990-09-13 Werner Weitschies Verfahren zur bestimmung des aufenthaltsortes und der bewegung von objekten durch ihre markierung als magnetisches moment
CN1056049C (zh) * 1994-02-02 2000-09-06 湖南省商业科技研究所 一种磁疗食品的制备方法
EP0928155A1 (de) 1996-08-16 1999-07-14 Roche Diagnostics GmbH Kontrollsystem für die überwachung der regelmässigen einnahme eines medikamentes
JP2004331750A (ja) 2003-05-02 2004-11-25 Canon Inc ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
EP1557151A1 (en) * 2004-01-22 2005-07-27 F. Hoffmann-La Roche Ag Solid dosage form
CN100355454C (zh) 2005-10-25 2007-12-19 南京工业大学 磁热疗用纳米磁粉-抗人肝癌单抗HAb18靶向药物
EP1880716A1 (en) 2006-07-19 2008-01-23 Sandoz AG Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
DE102008033662A1 (de) 2008-07-11 2010-01-14 Technische Universität Ilmenau Pharmakologische Darreichungsform und Vorrichtung und Verfahren zur kontinuierlichen Lokalisierung und Verfolgung des Auflösevorganges dieser

Also Published As

Publication number Publication date
CA2772708C (en) 2017-07-11
KR101731130B1 (ko) 2017-05-11
BR112012004967B1 (pt) 2021-05-11
ES2528494T3 (es) 2015-02-10
SI2473095T1 (sl) 2015-02-27
US9050256B2 (en) 2015-06-09
IL217897A0 (en) 2012-03-29
IL217897A (en) 2014-06-30
US20120143039A1 (en) 2012-06-07
CN102573612B (zh) 2015-07-08
JP2013503831A (ja) 2013-02-04
JP5868319B2 (ja) 2016-02-24
EP2473095A1 (en) 2012-07-11
EP2473095B1 (en) 2014-11-12
CN102573612A (zh) 2012-07-11
MX2012002677A (es) 2012-04-11
CA2772708A1 (en) 2011-03-10
KR20120060210A (ko) 2012-06-11
WO2011026808A1 (en) 2011-03-10
HK1168016A1 (en) 2012-12-21
WO2011026808A8 (en) 2012-03-15
BR112012004967A2 (pt) 2016-04-05
PL2473095T3 (pl) 2015-04-30

Similar Documents

Publication Publication Date Title
MX2012002677A (es) Forma farmaceutica oral, que consta de al menos un agente activo, sustancias auxiliares de formulacion y particulas magnetizables.
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
BRPI0607569A2 (pt) composição farmacêutica compreendendo estatina e ácidos graxos Èmega-3, na forma de dosagem unitária
BR112015008186A2 (pt) formulação de um anticorpo estável e de baixa viscosidade
BRPI0615292A8 (pt) composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
EA201400972A1 (ru) Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения
BRPI0714399B8 (pt) composição farmacêutica líquida oral
BR112015024274A2 (pt) agente antiestático, composição de agente antiestático, composição de resina antiestática e artigo moldado
MX2020005942A (es) Delgada pelicula oral con alta carga de agente activo.
MX389052B (es) Formulaciones de insulina de accion prolongada.
BR122020001787A8 (pt) Conjugado de anticorpo-agente ativo, seus métodos de preparação, sua composição e seu uso
NZ619857A (en) A fast dissolving pharmaceutical composition
CO6751287A2 (es) Composición antigénetica de micobacteria
BR112015000203A2 (pt) formulações de etanercept que exibem redução marcada em partículas sub-visíveis
EA201270050A1 (ru) Нанодисперсия лекарственного средства и способ ее получения
CL2016000950A1 (es) Composición farmacéutica acuosa que comprende insulina glulisina y metionina; kit farmacéutico; uso en el tratamiento de la diabetes tipo 1 ó 2.
AR072347A1 (es) Composiciones de complejo de ciclopropeno
IN2014CN03307A (cg-RX-API-DMAC7.html)
AR053737A1 (es) Formulacion pediatrica de topiramato
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
EP4527855A3 (en) Stable igg4 based binding agent formulations
CL2012003168A1 (es) Composicion farmaceutica que comprende una solucion acuosa de minociclina y un cation divalente o trivalente en una proporcion mayor de 2:1 con respecto a la minociclina; metodo de preparacion; kit y uso en el tratamiento de infecciones bacterianas.
PE20210413A1 (es) Formulacion liquida estable que comprende etelcalcetida (amg416), un agente tamponante y agente de tonicidad
BR112014016589A8 (pt) método e fluido de tratamento subterrâneo
CL2012001940A1 (es) Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/08/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/08/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved

Owner name: ROEHM GMBH (DE)

B25G Requested change of headquarter approved

Owner name: ROEHM GMBH (DE)

B25A Requested transfer of rights approved

Owner name: EVONIK DEGUSSA GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: EVONIK OPERATIONS GMBH (DE)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2845 DE 15-07-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.